Adenylate Cyclase/Protein Kinase A Signaling Pathway Enhances Angiogenesis Through Induction of Vascular Endothelial Growth Factor In Vivo.
-
- Amano Hideki
- Department of Pharmacology, Kitasato University School of Medicine
-
- Ando Kao
- Department of Pharmacology, Kitasato University School of Medicine
-
- Minamida Satoshi
- Department of Pharmacology, Kitasato University School of Medicine
-
- Hayashi Izumi
- Department of Pharmacology, Kitasato University School of Medicine
-
- Ogino Michiko
- Department of Pharmacology, Kitasato University School of Medicine
-
- Yamashina Shohei
- Department of Anatomy, Kitasato University School of Medicine
-
- Yoshimura Hirokuni
- Department of Thoracic Surgery, Kitasato University School of Medicine
-
- Majima Masataka
- Department of Pharmacology, Kitasato University School of Medicine
Search this article
Description
We previously reported that endogenous prostaglandins (PGs) may increase cAMP facilitated angiogenesis through the induction of vascular endothelial growth factor (VEGF) in rat sponge implantation models. In the present experiment, we tested whether or not adenylate cyclase / protein kinase A (AC/PKA)-dependent VEGF induction enhanced angiogenesis in this model. Topical daily injections of 8-bromo-cAMP enhanced angiogenesis in a dose-dependent manner. Forskolin, an activator of AC, also facilitated angiogenesis as did amrinone, an inhibitor of phosphodiesterase. VEGF induction was confirmed by the increased levels in the fluids in the sponge matrix after topical injection of 8-bromo-cAMP. Immunohistochemical investigation further revealed the VEGF-expressed cells in the sponge granulation tissues to be fibroblasts, and the intensity of positive reactions was enhanced by 8-bromo-cAMP, forskolin and amrinone. Angiogenesis without topical injections of the above compounds was suppressed by SQ22,536, an inhibitor for AC, or H-89, an inhibitor for PKA, with concomitant reductions in VEGF levels. Daily topical injections of neutralizing antibody or anti-sense oligonucleotide against VEGF significantly suppressed angiogenesis. PGE2-induced angiogenesis was suppressed with SQ22,536 or H-89. These results suggested that AC/PKA-dependent induction of VEGF certainly enhanced angiogenesis and that pharmacological tools for controlling this signaling pathway may be able to facilitate the management of conditions involving angiogenesis.
Journal
-
- The Japanese Journal of Pharmacology
-
The Japanese Journal of Pharmacology 87 (3), 181-188, 2001
The Japanese Pharmacological Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679262075392
-
- NII Article ID
- 10007368353
-
- NII Book ID
- AA00691188
-
- COI
- 1:CAS:528:DC%2BD3MXovVylsLk%3D
-
- ISSN
- 13473506
- 00215198
-
- NDL BIB ID
- 5984836
-
- PubMed
- 11885966
-
- Web Site
- http://id.ndl.go.jp/bib/5984836
- https://ndlsearch.ndl.go.jp/books/R000000004-I5984836
- https://api.elsevier.com/content/article/PII:S002151981930263X?httpAccept=text/xml
- https://api.elsevier.com/content/article/PII:S002151981930263X?httpAccept=text/plain
- https://search.jamas.or.jp/link/ui/2002101973
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed